50 results on '"Maini, Brijeshwar"'
Search Results
2. TCT-131 Survival Benefit when using Impella 2.5 Percutaneous LVAD prior to PCI of Unprotected Left Main Culprit Vessel in Patients with Acute Myocardial Infarction Complicated by Cardiogenic Shock.
3. SYMPTOMATIC IMPROVEMENT WITH MITRACLIP THERAPY FOR PROHIBITIVELY HIGH-RISK DMR PATIENTS.
4. IMPROVEMENT IN QUALITY OF LIFE IN PATIENTS WITH DEGENERATIVE MITRAL REGURGITATION ST PROHIBITIVE SURGICAL RISK FOLLOWING TRANSCATHETER MITRAL VALVE REPAIR WITH THE MITRACLIP SYSTEM.
5. PERCUTANEOUS CARDIAC ASSIST DEVICES COMPARED WITH SURGICAL HEMODYNAMIC SUPPORT ALTERNATIVES: COST–EFFECTIVENESS IN THE EMERGENT SETTING
6. COST-EFFECTIVENESS OF IMPELLA HEMODYNAMIC SUPPORT IN THE EMERGENT CARE PATIENT GROUP
7. IN VIVO LIPID CORE PLAQUE BURDEN AND SPATIAL DISTRIBUTION IN PATIENTS WITH UNSTABLE ANGINA AND NQMI: A NEAR-INFRARED SPECTROSCOPY STUDY
8. COST-EFFECTIVENESS AND QUALITY OF LIFE IMPROVEMENTS: IMPELLA HEMODYNAMIC SUPPORT COMPARED WITH INTRA- AORTIC BALLOON PUMP IN HIGH RISK PATIENTS RECEIVING PCI
9. ASSOCIATION OF LARGE LIPID CORE PLAQUE DETECTED BY NEAR INFRARED SPECTROSCOPY WITH POST PERCUTANEOUS CORONARY INTERVENTION MYOCARDIAL INFARCTION
10. Complications and Failure Modes of Polymer-Jacketed Guidewires; Insights From the MAUDE Database.
11. Amplatzer Amulet Left Atrial Appendage Occluder Versus Watchman Device for Stroke Prophylaxis (Amulet IDE): A Randomized, Controlled Trial.
12. The Healthy, Aging, and Diseased Kidney: Relationship with Cardiovascular Disease.
13. Incidence of Early Atrial Fibrillation After Transcatheter versus Surgical Aortic Valve Replacement: A Meta-Analysis of Randomized Controlled Trials.
14. 2-Year Outcomes After Stenting of Lipid-Rich and Nonrich Coronary Plaques.
15. 4D Volume Intracardiac Echocardiography for Intraprocedural Guidance of Transcatheter Left Atrial Appendage Closure.
16. Device-Related Thrombus After Left Atrial Appendage Closure: Incidence, Predictors, and Outcomes.
17. Percutaneous Closure of Patent Foramen Ovale in Patients With Migraine: The PREMIUM Trial.
18. Impella 2.5 initiated prior to unprotected left main PCI in acute myocardial infarction complicated by cardiogenic shock improves early survival.
19. Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients.
20. 3-Year Outcomes in High-Risk Patients Who Underwent Surgical or Transcatheter Aortic Valve Replacement.
21. TCT-493 Factors Predicting Canted Deployment of Transcatheter Aortic Valve Replacement (TAVR).
22. 2-Year Outcomes in Patients Undergoing Surgical or Self-Expanding Transcatheter Aortic Valve Replacement.
23. The Current Use of Impella 2.5 in Acute Myocardial Infarction Complicated by Cardiogenic Shock: Results from the USpella Registry.
24. A CASE OF MECHANICAL HEMOLYSIS MANAGED BY VALVE-IN-VALVE TRANSCATHETER MITRAL VALVE REPLACEMENT.
25. A CASE OF MULTIPLE DEVICE RELATED THROMBI.
26. A RARE CASE OF VERY LATE LEAFLET THROMBOSIS AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR).
27. TRANSCATHETER EDGE-TO-EDGE MITRAL VALVE REPAIR: A NATIONAL TREND ANALYSIS.
28. CLOSING THE SEPTAL DOOR FOR TRANSCATHETER EDGE-TO-EDGE MITRAL VALVE REPAIR: A REGISTRY STUDY.
29. SEVERE PPM FOLLOWING TAVR IN SMALL ANNULUS IN SUPRA VERSUS INTRA-ANNULAR VALVE.
30. DEVELOPMENT OF A SCORING SYSTEM FOR PREDICTING HIGH RESIDUAL GRADIENT AT PRE-DISCHARGE ECHOCARDIOGRAPHY FOLLOWING TAVR.
31. THE ROLE OF TRANSCATHETER AORTIC VALVE REPLACEMENT IN LOW-FLOW, LOW-GRADIENT AORTIC STENOSIS: INSIGHTS FROM THE EVOLUT LOW RISK TRIAL.
32. UTILIZATION AND IN-HOSPITAL OUTCOMES OF TRANSESOPHAGEAL ECHOCARDIOGRAPHY VERSUS INTRACARDIAC ECHOCARDIOGRAPHY FOR LEFT ATRIAL APPENDAGE CLOSURE: INSIGHT FROM NATIONWIDE DATABASE.
33. HYBRID CARDIAC ABLATION AND LEFT ATRIAL APPENDAGE CLOSURE: INSIGHT FROM NATIONAL DATABASE.
34. POPULATION MANAGEMENT CONSIDERATIONS FOR PAYERS AND ACCOUNTABLE CARE ORGANIZATIONS: BUDGET IMPACT ANALYSIS FOR PERCUTANEOUS CARDIAC ASSIST DEVICES
35. A Prospective, Randomized Clinical Trial of Hemodynamic Support With Impella 2.5 Versus Intra-Aortic Balloon Pump in Patients Undergoing High-Risk Percutaneous Coronary Intervention.
36. Intra-atrial mass-thrombus versus myxoma, post-amplatzer atrial septal defect closure device deployment.
37. Intra-Atrial Mass–Thrombus Versus Myxoma, Post-Amplatzer Atrial Septal Defect Closure Device Deployment
38. A prospective multicenter registry of laser therapy for degenerated saphenous vein graft stenosis: the COronary graft Results following Atherectomy with Laser (CORAL) trial
39. Protected Carotid Stenting in High-Risk Patients With Severe Carotid Artery Stenosis
40. TRANSCATHETER INTERVENTIONS FOR CONCOMITANT SEVERE AORTIC STENOSIS AND SEVERE MITRAL REGURGITATION.
41. CHANGE IN TRANSMITRAL GRADIENT IN PATIENTS WITH CONCOMITANT MITRAL STENOSIS UNDERGOING TRANSCATHETER AORTIC VALVE REPLACEMENT.
42. TEMPORAL TREND IN ATRIAL FIBRILLATION AND ATRIAL FLUTTER ASSOCIATED MORTALITY IN THE UNITED STATES (1999-2017).
43. Contrast-Induced Acute Kidney Injury: Review and Practical Update.
44. Accuracy of Commonly-Used Imaging Modalities in Assessing Left Atrial Appendage for Interventional Closure: Review Article.
45. TCT-121 Mechanical Circulatory Support in Acute Myocardial Infarction Complicated by Cardiogenic Shock: Insights from the cVAD Registry.
46. LACK OF ASSOCIATION BETWEEN LDL-CHOLESTEROL, PLAQUE BURDEN AND LIPID-RICH PLAQUE IN CORONARY LESIONS REQUIRING PCI: THE COLOR REGISTRY.
47. HEALTH STATUS AFTER TRANSCATHETER OR SURGICAL AORTIC VALVE REPLACEMENT IN HIGH-RISK PATIENTS WITH SEVERE AORTIC STENOSIS: RESULTS FROM THE COREVALVE US PIVOTAL TRIAL.
48. FACTORS ASSOCIATED WITH A REDUCTION OF LIPID CORE PLAQUE IN PATIENTS UNDERGOING PCI: NEAR-INFRARED SPECTROSCOPY RESULTS FROM THE COLOR REGISTRY.
49. IMPELLA IMPROVES CLINICAL OUTCOMES WHEN EXTENSIVE REVASCULARIZATION IS PERFORMED: THE PROTECT II STUDY
50. INTRACORONARY LIPID BURDEN AT BIFURCATIONS: RESULTS FROM THE COLOR REGISTRY
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.